Answers are grounded in this paper and cite their sources.
Physalis peruviana L. is a rich source of bioactive withanolides; however, its phytochemical diversity remains incompletely explored. In the present study, a phytochemical investigation of P. peruviana cultivated in Vietnam resulted in the isolation of eleven secondary metabolites, including one new withanolide, withaperuvin VN A (1), together with ten known compounds. Structural elucidation of the isolated compounds was accomplished through the analysis of 1D and 2D NMR spectroscopic data in combination with HR-ESI-MS measurements. The ability of the isolated compounds to inhibit xanthine oxidase and α-glucosidase was investigated. The resulting data expand current knowledge of the chemical constituents of P. peruviana and offer further insights into its chemotaxonomic characteristics.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: